Administering Monoclonal Antibody Therapy in Severe #COVID19 Patients, Who Have Not ... - Latest Tweet by IANS Tweets

Administering monoclonal antibody therapy in severe #COVID19 patients, who have not mounted a natural antibody response of their own, can reduce the risk of death by 20 per cent, according to results of a clinical trial. pic.twitter.com/LuzkBPC1kr— IANS Tweets (@ians_india) June 16, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)